We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-5.98%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.92B
AUM Growth
-$382M
Cap. Flow
-$115M
Cap. Flow %
-5.98%
Top 10 Hldgs %
45.28%
Holding
275
New
41
Increased
31
Reduced
101
Closed
38

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$24.8M
2
ASTH icon
Astrana Health
ASTH
+$16.6M
3
KSPI icon
Kaspi.kz JSC
KSPI
+$15.8M
4
LLY icon
Eli Lilly
LLY
+$15.2M
5
GPC icon
Genuine Parts
GPC
+$13M

Top Sells

Rank Stock Value
1
UWMC icon
UWM Holdings
UWMC
+$30.9M
2
WDC icon
Western Digital
WDC
+$24.7M
3
HRMY icon
Harmony Biosciences
HRMY
+$13.6M
4
SUNC
SunocoCorp LLC
SUNC
+$11.6M
5
GXO icon
GXO Logistics
GXO
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 23.91%
2 Consumer Discretionary 7.8%
3 Financials 6.79%
4 Industrials 3.72%
5 Materials 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PURR
76
Hyperliquid Strategies Inc
PURR
$1.22B
$4.33M 0.23%
850,000
-740,000
-47% -$3.35M
VKTX icon
77
Viking Therapeutics
VKTX
$4.04B
$4.23M 0.22%
130,000
-52,000
-29% -$1.67M
TBPH icon
78
Theravance Biopharma
TBPH
$874M
$4.06M 0.21%
+250,000
New +$4.42M
RNA
79
Atrium Therapeutics
RNA
$197M
$4.01M 0.21%
+300,000
New +$4.21M
CZR icon
80
Caesars Entertainment
CZR
$6.1B
$3.96M 0.21%
150,000
-94,000
-39% -$2.24M
MREO
81
Mereo BioPharma
MREO
$45.9M
$3.96M 0.21%
12,000,000
-3,025,000
-20% -$1.3M
LULU icon
82
PUT
lululemon athletica
LULU
$13B
$3.83M 0.2%
25,000
– –
SAAQ
83
Space Asset Acquisition Corp
SAAQ
$319M
$3.73M 0.19%
+375,000
New +$3.73M
NVGS icon
84
Navigator Holdings
NVGS
$1.34B
$3.6M 0.19%
186,000
– –
ABEO icon
85
Abeona Therapeutics
ABEO
$345M
$3.45M 0.18%
770,000
– –
BNED icon
86
Barnes & Noble Education
BNED
$412M
$3.36M 0.18%
380,000
+30,000
+9% +$259K
IVVD icon
87
Invivyd
IVVD
$180M
$3.27M 0.17%
2,515,000
-385,000
-13% -$707K
GUTS icon
88
Fractyl Health
GUTS
$123M
$3.08M 0.16%
6,727,235
+679,615
+11% +$627K
CRESY
89
Cresud
CRESY
$794M
$3.05M 0.16%
240,000
-183,552
-43% -$2.23M
COIN icon
90
PUT
Coinbase
COIN
$41.7B
$2.97M 0.15%
17,000
-35,500
-68% -$6.99M
IFRX icon
91
InflaRx
IFRX
$256M
$2.96M 0.15%
3,315,000
– –
IMUX icon
92
Immunic
IMUX
$182M
$2.72M 0.14%
+245,000
New +$2.19M
RXO icon
93
RXO
RXO
$4.23B
$2.63M 0.14%
180,000
-177,953
-50% -$2.61M
ALDX icon
94
Aldeyra Therapeutics
ALDX
$91.7M
$2.53M 0.13%
1,500,000
-30,000
-2% -$131K
LAFA
95
LaFayette Acquisition Corp
LAFA
$2.49M 0.13%
250,000
– –
CNTB
96
Connect Biopharma Holdings
CNTB
$135M
$2.36M 0.12%
+900,000
New +$2.35M
IOVA icon
97
PUT
Iovance Biotherapeutics
IOVA
$2.23B
$2.26M 0.12%
+644,300
New +$2.06M
HHH icon
98
Howard Hughes
HHH
$3.93B
$2.25M 0.12%
35,500
-2,500
-7% -$187K
PANL icon
99
Pangaea Logistics
PANL
$501M
$2.19M 0.11%
309,500
-185,500
-37% -$1.46M
NTGR icon
100
NETGEAR
NTGR
$669M
$2.18M 0.11%
+100,000
New +$2.16M
2 3
4
5 6

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, 683 Capital Management held 275 positions worth $1.92B, down 17% from $2.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

683 Capital Management withdrew a net $115M in Q1 2026, closing 38 positions and reducing 101 holdings. Its most notable exit was UWM Holdings, an estimated $30.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Astrana Health worth $17.2M.

  • 683 Capital Management's largest Q1 2026 buy was Astrana Health: 700,000 shares worth $17.2M.
  • 683 Capital Management added most to Becton Dickinson in Q1 2026, an estimated $24.8M increase.
  • 683 Capital Management's biggest Q1 2026 reduction was GXO Logistics, cutting an estimated $10.6M.
  • 683 Capital Management fully exited UWM Holdings in Q1 2026, selling an estimated $30.9M.
  • 683 Capital Management's ten largest holdings make up 45% of its $1.92B portfolio in Q1 2026.
  • 683 Capital Management opened 41 new positions and closed 38 in Q1 2026.
  • 683 Capital Management's portfolio value fell 17% quarter-over-quarter to $1.92B.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.